Displaying 1 to 11 of 11 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Anthera Pharmaceuticals Inc |
United States | N/A Active |
||
|
Arena Pharmaceuticals Inc |
United States | N/A |
||
|
|
Aspreva International Ltd |
Canada | Series A |
||
|
|
Asthmatx Inc |
United States | N/A |
||
|
|
BaroFold Inc Applies its patented protein folding technology to improve the efficacy and lower the cost of protein therapeutics. |
United States | N/A Active |
||
|
|
Devax Inc Developer of a drug-eluting stent for the treatment of vascular bifurcations. |
United States | N/A Active |
||
|
|
Gemin X Pharmaceuticals Inc |
Canada | 1 Jul 2008 | Series C |
|
|
|
Lux Biosciences Inc Clinical stage biotechnology company specializing in the development and commercialization of innovative medications for serious ophthalmic diseases. |
United States | N/A |
||
|
|
Mpex Pharmaceuticals Inc |
United States | N/A |
||
|
|
Ophthotech Corp Clinical-stage biotechnology company, engages in developing and commercializing therapies for wet and dry age-related macular degeneration. |
United States | N/A |
||
|
|
Rigel Pharmaceuticals Inc |
United States | N/A |